We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Comparison of Sugammadex Dose for Intraoperative Neuromonitoring in Thyroid Surgery: A Randomized Controlled Trial.
- Authors
Chai, Young Jun; Lee, Jung‐Man; Won, Dongwook; Lee, Jiwon; Hwang, Jin‐Young; Kim, Tae Kyong; Chang, Jee‐Eun; Kim, Hyerim; Yang, Hyo Jun; Min, Seong‐Won
- Abstract
Objectives/Hypothesis: To compare effect of 1 and 2 mg/kg of sugammadex on the incidence of intraoperative bucking and intraoperative neuromonitoring (IONM) quality in thyroid surgery. Study Design: Randomized controlled trial. Methods: Patients qualified for thyroid surgery with IONM were eligible for this double‐blind, randomized, controlled trial. After tracheal intubation with 0.6 mg/kg rocuronium, 1 or 2 mg/kg of sugammadex was administered to patients in group I or II, respectively. The quality of the IONM for the external branch of the superior laryngeal nerve (EBSLN) was evaluated (strong/intermediate/weak). The initial amplitude of electromyography for the vagus nerve (V1) and the recurrent laryngeal nerve (R1) were recorded. Intraoperative bucking movements was recorded. Results: A total of 102 patients (51 in each group) completed the study. Time from sugammadex administration to initial checking for the EBSLN was not different between group I and II (25.0 ± 7.9 vs. 25.5 ± 9.0 minutes, P =.788). There was no difference in the neuromonitoring quality for the EBSLN between group I and II (strong/intermediate/weak: 46/5/0 vs. 50/1/0, P =.205). The amplitudes of V1 (1,086.3 ± 673.3 μV vs. 1,161.8 ± 727.5 μV, P =.588) and R1 (1,328.2 ± 934.1 μV vs. 1,410.5 ± 919.6 μV, P =.655) were comparable between the groups. Patients who experienced bucking were significantly fewer in the group I than the group II (13.7% vs. 35.3%, P =.020). Conclusion: A dose of 1 mg/kg sugammadex induced less bucking than 2 m/kg while providing comparable IONM quality during thyroid surgery. Level of Evidence: 2 Laryngoscope, 131:2154–2159, 2021
- Subjects
SUGAMMADEX; RECURRENT laryngeal nerve; LARYNGEAL nerves; RANDOMIZED controlled trials; THYROID gland
- Publication
Laryngoscope, 2021, Vol 131, Issue 9, p2154
- ISSN
0023-852X
- Publication type
Article
- DOI
10.1002/lary.29515